These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14748583)

  • 1. Water-soluble camptothecin derivatives that are intrinsic topoisomerase I poisons.
    Rahier NJ; Eisenhauer BM; Gao R; Jones SH; Hecht SM
    Org Lett; 2004 Feb; 6(3):321-4. PubMed ID: 14748583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 14-azacamptothecin: a potent water-soluble topoisomerase I poison.
    Cheng K; Rahier NJ; Eisenhauer BM; Gao R; Thomas SJ; Hecht SM
    J Am Chem Soc; 2005 Jan; 127(3):838-9. PubMed ID: 15656613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of camptothecin derivatives on topoisomerase I-mediated DNA structure modification.
    Wang X; Wang LK; Kingsbury WD; Johnson RK; Hecht SM
    Biochemistry; 1998 Jun; 37(26):9399-408. PubMed ID: 9649322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the 20-hydroxyl group in camptothecin binding by the topoisomerase I-DNA binary complex.
    Wang X; Zhou X; Hecht SM
    Biochemistry; 1999 Apr; 38(14):4374-81. PubMed ID: 10194356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Camptothecin: current perspectives.
    Thomas CJ; Rahier NJ; Hecht SM
    Bioorg Med Chem; 2004 Apr; 12(7):1585-604. PubMed ID: 15028252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Camptothecins inhibit the utilization of hydrogen peroxide in the ligation step of topoisomerase I catalysis.
    Lisby M; Krogh BO; Boege F; Westergaard O; Knudsen BR
    Biochemistry; 1998 Jul; 37(30):10815-27. PubMed ID: 9692972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luotonin A. A naturally occurring human DNA topoisomerase I poison.
    Cagir A; Jones SH; Gao R; Eisenhauer BM; Hecht SM
    J Am Chem Soc; 2003 Nov; 125(45):13628-9. PubMed ID: 14599178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of 10,11-methylenedioxy-14-azacamptothecin.
    Elban MA; Sun W; Eisenhauer BM; Gao R; Hecht SM
    Org Lett; 2006 Aug; 8(16):3513-6. PubMed ID: 16869648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin.
    Eng WK; Faucette L; Johnson RK; Sternglanz R
    Mol Pharmacol; 1988 Dec; 34(6):755-60. PubMed ID: 2849043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 14-azacamptothecin, a water-soluble topoisomerase I poison.
    Rahier NJ; Cheng K; Gao R; Eisenhauer BM; Hecht SM
    Org Lett; 2005 Mar; 7(5):835-7. PubMed ID: 15727453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the role of E-ring oxygen atoms in the binding of camptothecin to the topoisomerase I-DNA covalent binary complex.
    Rahier NJ; Eisenhauer BM; Gao R; Thomas SJ; Hecht SM
    Bioorg Med Chem; 2005 Feb; 13(4):1381-6. PubMed ID: 15670945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal encapsulation increases the activity of the topoisomerase I inhibitor topotecan.
    Subramanian D; Muller MT
    Oncol Res; 1995; 7(9):461-9. PubMed ID: 8835290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthocyanidins modulate the activity of human DNA topoisomerases I and II and affect cellular DNA integrity.
    Habermeyer M; Fritz J; Barthelmes HU; Christensen MO; Larsen MK; Boege F; Marko D
    Chem Res Toxicol; 2005 Sep; 18(9):1395-404. PubMed ID: 16167831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Water soluble inhibitors of topoisomerase I: quaternary salt derivatives of camptothecin.
    Lackey K; Sternbach DD; Croom DK; Emerson DL; Evans MG; Leitner PL; Luzzio MJ; McIntyre G; Vuong A; Yates J; Besterman JM
    J Med Chem; 1996 Feb; 39(3):713-9. PubMed ID: 8576914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrophilic camptothecin analogs that form extremely stable cleavable complexes with DNA and topoisomerase I.
    Wadkins RM; Bearss D; Manikumar G; Wani MC; Wall ME; Von Hoff DD
    Cancer Res; 2004 Sep; 64(18):6679-83. PubMed ID: 15374984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of human DNA topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: restoration of sensitivity of the cells to the antitumor drug camptothecin.
    Bjornsti MA; Benedetti P; Viglianti GA; Wang JC
    Cancer Res; 1989 Nov; 49(22):6318-23. PubMed ID: 2553253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and properties of camptothecin derivatives, their protonated forms, and model interaction with the topoisomerase I-DNA complex.
    Ivanova B; Spiteller M
    Biopolymers; 2012 Feb; 97(2):134-44. PubMed ID: 21898362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Camptothecin resistance from a single mutation changing glycine 363 of human DNA topoisomerase I to cysteine.
    Benedetti P; Fiorani P; Capuani L; Wang JC
    Cancer Res; 1993 Sep; 53(18):4343-8. PubMed ID: 8395982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and topoisomerase I inhibitory properties of luotonin A analogues.
    Cagir A; Eisenhauer BM; Gao R; Thomas SJ; Hecht SM
    Bioorg Med Chem; 2004 Dec; 12(23):6287-99. PubMed ID: 15519171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and cytotoxicity of water soluble quaternary salt derivatives of camptothecin.
    Zu YG; Li QY; Fu YJ; Wang W
    Bioorg Med Chem Lett; 2004 Aug; 14(15):4023-6. PubMed ID: 15225719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.